Category: News

March 13, 2019 TRiNDS Clinical Operations Services Clinical trials can be difficult to manage. Trial sites around the world have different local institutional and ethical rules. Central study teams work with multiple different scientific and company stakeholders. Regulations governing clinical trials and drug development require comprehensive and accurate record keeping. And everything needs to be… Read more »

TRiNDS Patient Science Liaison Services

February 15, 2019 TRiNDS Patient Science Liaison Services Rare disease clinical trials are not the same as other trials. The paperwork and research rules might be the same, but everything else is different. The tests are different, the providers are different, but most of all, the families are different. People who are coping with a… Read more »

Clinical Research Professionals: Approaches to Informed Consent

January 30, 2019 Clinical Research Professionals: Approaches to Informed Consent The first step of any research study is the informed consent process. Every patient and their family is asked to decide whether or not to enroll in a study through a discussion with site staff and study doctors. Even though informed consent is important, finding… Read more »

Genetic Disorders in Clinical Trials

December 20, 2018 Genetic Disorders in Clinical Trials We specialize in neuromuscular and rare disease clinical trials. The science is fascinating, but there are a lot more complexities than in other types of clinical trials. Many neuromuscular and other rare diseases have genetic causes, which makes everything even more complicated. It’s important to design your… Read more »

Early Bird Registration for the MDA Conference Closes Soon

December 5, 2018 Early Bird Registration for the MDA Conference Closes Soon Even though it’s winter here in the US, spring is just around the corner. In April, clinical providers and researchers will meet for the first combined MDA Clinical and Research Conference in Orlando, Florida. This five day conference is your opportunity to learn… Read more »

Frequently Asked Questions: How do You Work with Clients?

November 14, 2018 Frequently Asked Questions: How do You Work With Clients? TRiNDS is a specialized neuromuscular contract research organization offering expert level support for clinical trials, post marketing studies, and academic research. Our clients are biopharmaceutical companies working to develop new treatments for neuromuscular disorders around the world. Our approach is to work in… Read more »

New Supplements: Duchenne Muscular Dystrophy Care Guidelines

November 9, 2018 New Supplements: Duchenne Muscular Dystrophy Care Guidelines The October 2018 issue of Pediatrics included a set of critical documents for the good care of children with Duchenne Muscular Dystrophy (DMD). The special supplement included a series of 12 articles outlining best practices for multidisciplinary management of DMD. These articles build on the… Read more »

Happy Fall from the TRiNDS Team!

October 31, 2018 Happy Fall from the TRiNDS Team! Last week, TRiNDS staff travelled to beautiful Central Pennsylvania from all over the country for our annual retreat. We spent two days together to review our company progress, update our annual training, and to plan for the future. We did take some time for play –… Read more »

FDA Invites Public Comment On Adaptive Designs

October 25, 2018 FDA Invites Public Comment On Adaptive Designs The Food and Drug Administration (FDA) released an updated draft guidance to industry in early October entitled, “Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry.” The draft guidance reviews best practices for trial design, analysis, and reporting of clinical trials using… Read more »